When she heard the stunning news that rebels had brought an end to Syria's decades-old regime, Hayat al-Turki headed for a ...

A study by Indiana University School of Medicine researchers sheds new light on how Toxoplasma gondii parasites make the ...

All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...

The moment more than 50 years of the Assad family’s rule of Syria came to an end on Sunday, Syrians in the country and around ...

Fate Therapeutics (FATE) presented new clinical and translational data from the company’s FT819 Phase 1 Autoimmunity study for ...

In molecular biology, RNA modifications were traditionally associated with static structural components like rRNAs and tRNAs. However, advancements such as antibody immunoprecipitation and ...

The new paper, "The enhancer module of integrator controls cell identity and early neural fate commitment" was published in the journal, Nature Cell Biology. "By achieving a better understanding ...

Film trilogy to stream with audio in Japanese, English; subtitles in English, Spanish, Portuguese Aniplex of America describes the first film in the trilogy: The boy wished to protect the girl ...

It is supremely important to both directors that they keep the spirit of Narita's novels alive when creating the anime version. “I have always maintained the basic principle of adhering to the ...

The final conclusion is that Fate Therapeutic has done well to develop its pipeline full of cell therapy candidate. FT819 is being developed from the pipeline as a CAR T-cell therapy for the ...

SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...